Navigation Links
BBK Worldwide Foresees Expanding Global Demand for Patient Recruitment Technology
Date:6/17/2009

Releases TrialCentralNet(SM) 5.0 to Meet Site and Sponsor Needs

for Expanded Metrics that Accelerate Patient Enrollment

NEWTON, Mass., June 17 /PRNewswire/ -- Anticipating the increasing sophistication of the global clinical trial patient recruitment marketplace, BBK Worldwide announces the release of TrialCentralNet(SM) (TCN) 5.0, the leading patient recruitment management system (PRMS) on the market. The latest version incorporates recent advances in technology, BBK's evolving institutional knowledge, and extensive user feedback gathered over hundreds of TCN deployments and tens of thousands of users to optimize patient recruitment planning and accelerate patient enrollment for multinational trials.

The new features and upgrades of TCN 5.0 respond to the need for a global technology specifically designed to mitigate the six key risk areas of study enrollment by providing: 1) a robust communications infrastructure; 2) tools for proactive planning of enrollment efforts; 3) targeted criteria for site selection; 4) a well-defined recruitment material development and implementation process; 5) efficiencies for enrollment of patients; and 6) instantaneous reporting on randomization and retention metrics. "For the world of increasingly savvy Internet users -- the Facebook/Twitter generation -- who demand interactivity, TCN 5.0 provides each study audience with secure and instant access to applicable recruitment data while safeguarding privacy and scientific validity," said Joan F. Bachenheimer, founding principal of BBK Worldwide.

Over its 10-year history on the clinical trial market, TCN has gained a reputation for intuitive use and seamless integration into site, monitor, and clinical team recruitment activities to ease their workloads and speed recruitment. Version 5.0 expands these functions for further application to global trials. New features include instantly customizable reports, streamli
'/>"/>

SOURCE BBK Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
2. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
3. Global Med Technologies(R) Extends Its Worldwide Outreach
4. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
5. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
6. New USAID grant helps Georgetown meet unmet family planning needs worldwide
7. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
8. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
9. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
10. Allscripts Featured in Microsoft HealthVault Worldwide Launch
11. Abortion Numbers Fall Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...earchers at the University of Warwick have discove...e the onset of early diabetic kidney disease. , K...rogressively in patients with type 2 diabetes. Ear...a. , The research is led by Dr Naila Rabbani and ...
...NSOCKET, R.I., Dec. 8 Fulfilling a commitment to ...flu shot, CVS/pharmacy, the,nation,s largest retai...ealth,care clinic in the U.S., announced that they...mark Corp. (NYSE: CVS ), launched,an integrated ...
... FRANCISCO ― Age alone should not determine ...ia or myelodysplastic syndrome receives a blood st...rs of the Center for International Blood and Marro... younger patients with transplants that are preced...
...SNO, Calif., Dec. 8 Over 56% of American Dietetic... concerned that the current,economic downturn will... to,maintain or achieve a healthy weight, accordin...expressed concern that the economic downturn would...
...HA, Neb., Dec. 8 Deaconess Hospital has entered a... Inc . to offer its Medicare-eligible patients acc...Medicare Advantage and Part D prescription drug pl...a, UnitedHealthcare, Coventry, CIGNA, Aetna, Pyram...
...ERLY HILLS, Calif., Dec. 8 The Lap Band or the,ad...vasive operation used as,an alternative medical we...ls.,Studies show with the FDA approval in 2001; La...s,the stomach smaller so that you eat less. It wor...
Other Medicine News:Health News:Vitamin B1 could reverse early-stage kidney disease in diabetes patients 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 3Health News:Older age doesn't affect survival after bone marrow transplant 2Health News:Dieticians & Nutritionists Concerned Economic Downturn Will Effect Patient Health and Diets. 2Health News:Deaconess Hospital Partners With Senior Market Sales to Expand Insurance Offering for Medicare-Eligible Patients 2Health News:Lap Band - Approximately 33 Percent of Adults in America are Obese LAP BAND Surgery Can Improve Your Life 2Health News:Lap Band - Approximately 33 Percent of Adults in America are Obese LAP BAND Surgery Can Improve Your Life 3
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)ACTON, Mass., Dec. 3 Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: HRC ), today announced the launch of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) busin
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 1TrinityCare Senior Living Announces Expansion into Louisiana 57948 2TrinityCare Senior Living Announces Expansion into Louisiana 57948 3Moroney 26 Gill Inc Launches New Website 57946 1Cynosure to Present at the Maxim Group Growth Conference 57944 1Cynosure to Present at the Maxim Group Growth Conference 57944 2
...iency and quality to routine urine microscopic ana...orescent flow cytometry with fully automated urine...ocessing are easily accommodated by the rack-based...igh volume laboratories. Fluorescent flow cytomet...
... incorporates a translucent inner sleeve into a pr... each needle load matches the proper load configur...dle options, the IsoSleeve™ system allows fo... giving you confidence that the needle load is cor...
...ish streaking machine. It will load, streak and st.... Automated streaking results in substantial cost ...tivity, improves isolation rates, standardizes str...A filtered personnel protection. In total, over 1/...
Acquidata Uromac Petite Urodynamics System
Medicine Products: